Clinical profile and treatment outcomes of Boerhaave's syndrome: A 13-year experience from an upper gastrointestinal surgical unit.
Boerhaave’s syndrome
Pittsburgh perforation severity score
spontaneous esophageal perforation
surgery
therapeutic endoscopy
Journal
Turkish journal of surgery
ISSN: 2564-6850
Titre abrégé: Turk J Surg
Pays: Turkey
ID NLM: 101704837
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
01
07
2022
accepted:
22
05
2023
medline:
7
12
2023
pubmed:
7
12
2023
entrez:
7
12
2023
Statut:
epublish
Résumé
IBoerhaave's syndrome (BS) is a rare, but potentially fatal condition, characterized by barogenic esophageal rupture and carries a high mortality. We aimed to study our institutional experience of managing patients with BS. A retrospective review of patients with BS presenting to a tertiary care centre from 2005 to 2018 was carried out in this study. Clinical presentation, diagnostic evaluations, treatments received, and treatment outcomes were studied. Perforations were classified as early (<24 hours) and delayed (>24 hours), based on the time elapsed. Surgical complications were graded using Clavien-Dindo grade. The Pittsburgh perforation severity score was correlated with short-term treatment outcomes. Of the 12 patients [male, 75%; mean (range) age, 53 (28-80) years] included, 10 patients had a delayed (>24 hours) presentation. Chest pain was the dominant symptom (58.3%); six patients presented either in shock (n= 1) or with organ failure (n= 3) or both (n= 2). All the perforations were sited in the lower thoracic esophagus, of which three were contained and nine were uncontained. The seal of the perforation was achieved by surgical repair in four patients (primary repair, 2; repair over a T-tube, 2) and endoscopic techniques in four patients (clipping, 1; stenting, 3). Sepsis drainage [surgical, 7 (open-5, minimally-invasive-2); non-surgical, 5] and feeding jejunostomy were performed in all patients. Five (41.7%) patients received a re-intervention. Median (range) hospital stay was 25.5 (12-101) days, 30-day operative morbidity was 50%, and there was one in-hospital death. The Pittsburgh perforation severity score was as follows: 2-5 in two patients and >5 in 10 patients; there were more delayed presentations, increased surgical interventions, post-procedure morbidity, and in-hospital mortality in the latter group, but the differences were statistically not significant. In 11 patients followed-up [median (range):1507 (17-5929) days], there was no disease recurrence, symptomatic reflux or dysphagia. Favourable treatment outcomes, including reduced mortality and organ preservation can be achieved for Boerhaave's perforations, through a multimodality approach. Minimally invasive, endoluminal or open surgical techniques may be safely utilized in its management. The Pittsburgh severity score can be a useful clinical tool that can be used to select the initial intervention and to predict treatment outcomes.
Identifiants
pubmed: 38058370
doi: 10.47717/turkjsurg.2023.5830
pmc: PMC10696438
doi:
Types de publication
Journal Article
Langues
eng
Pagination
177-189Informations de copyright
Copyright © 2023, Turkish Surgical Society.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors have no conflicts of interest to declare.
Références
Int J Surg. 2013;11(1):64-7
pubmed: 23219866
Endosc Int Open. 2018 Jan;6(1):E92-E97
pubmed: 29344568
BMC Surg. 2019 Aug 13;19(1):109
pubmed: 31409335
Ann Thorac Surg. 2011 May;91(5):1552-5
pubmed: 21435633
Ann R Coll Surg Engl. 2009 Jul;91(5):374-80
pubmed: 19409144
Surg Endosc. 2011 Aug;25(8):2492-7
pubmed: 21359901
Ann Surg. 1997 Apr;225(4):415-21
pubmed: 9114801
Ann R Coll Surg Engl. 2013 Nov;95(8):557-60
pubmed: 24165336
World J Emerg Surg. 2019 May 31;14:26
pubmed: 31164915
Ann Thorac Surg. 2009 Jul;88(1):194-8
pubmed: 19559223
J Trauma Acute Care Surg. 2012 Oct;73(4):1011-3
pubmed: 23026917
Pol Przegl Chir. 2016 Dec 1;88(6):365-372
pubmed: 28141555
Rev Esp Enferm Dig. 2020 Sep;112(9):669-674
pubmed: 32496118
Surg Endosc. 2021 Jul;35(7):3492-3505
pubmed: 32681374
Surgery. 2009 Oct;146(4):749-55; discussion 755-6
pubmed: 19789035
J Thorac Cardiovasc Surg. 2016 Apr;151(4):1002-9
pubmed: 26897241
Dis Esophagus. 2019 Feb 1;32(2):
pubmed: 30496380
Surg Endosc. 2019 Oct;33(10):3494-3502
pubmed: 31144123
J Thorac Dis. 2020 Aug;12(8):4411-4417
pubmed: 32944354
Scand J Gastroenterol. 2018 Apr;53(4):398-402
pubmed: 29523026
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
BMC Surg. 2020 Mar 2;20(1):41
pubmed: 32122343
Dis Esophagus. 2009;22(1):62-7
pubmed: 18847455
Dis Esophagus. 2017 Feb 1;30(3):1-6
pubmed: 27790804
Biomed Res Int. 2018 Jun 28;2018:8483401
pubmed: 30050944
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560